France · Series A startup

Who invested in Antabio

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $15MJul 2018
Investors
4
See who backed them

The rounds

  1. Jul 2018

Founders and team

From Antabio's own website: 18 on the team.

  • Marc LemonnierChief Executive Officer
  • Adeline LedouxVice-President Project Management & Regulatory Affairs
  • Gordon WaldronChief Financial Officer
  • Magdalena ZalacainChief Scientific Officer
  • Rienk PypstraChief Medical Officer
  • Agustina LlanosHead of Discovery & Clinical Microbiology
  • Cyrille DrouotHead of Quality Assurance
  • Daniel ArensonHead of CMC
  • David DaviesHead of Medicinal Chemistry
  • Jingjing SunGlobal Head of Business Development
  • Peter FennHead of Safety and DMPK
  • Carine DanaireExecutive Assistant & HR Manager
  • Charlotte Da SilvaLab Manager
  • Eugénie LahetProject Manager
  • Laura FabreClinical Project Manager
  • Pascale PielFinance & Administration Director
  • Paula BenoitRegulatory Affairs Manager
  • Simon LeirisCMC Manager and Senior Medicinal Chemist

Everyone who backed them

OmnesVC firm1round
Galia GestionPrivate equity1round
BNP Paribas DéveloppementCorporate VC1round
Turenne CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Antabio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

AMR Action FundVC firmPer its own site

Quick answers about Antabio

Who invested in Antabio?

Antabio's investors include Omnes, Galia Gestion, BNP Paribas Développement and Turenne Capital.

How much has Antabio raised?

Antabio has raised $15M across 1 round since 2018.

When did Antabio last raise?

Antabio's most recent round was a Series A of $15M in Jul 2018.

What was Antabio's biggest round?

Its most recent round, $15M in Jul 2018, is also its largest on record.

Who backed Antabio first?

Antabio's first round on record, in Jul 2018, was backed by Omnes, Galia Gestion and BNP Paribas Développement and 1 others.

What stage is Antabio at?

Antabio's latest named round is a Series A, in Jul 2018.

Where is Antabio based?

Antabio is based in France.

Companies like Antabio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.